Candriam Luxembourg S.C.A. »

Trevi Therapeutics shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.2M 774k 11.93

More positions owned by Candriam Luxembourg S.C.A.

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Abbvie (ABBV)
Alphabet Cap Stk Cl C (GOOG)
Gilead Sciences (GILD)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
McKesson Corporation (MCK)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Palo Alto Networks (PANW)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Trevi Therapeutics

NEA Management Company
BlackRock
Frazier Life Sciences Management
FMR
Vanguard Group
Vivo Capital
Vanguard Capital Management
Marshall Wace
Rubric Capital Management
Wellington Management Company
MPM Oncology Impact Management
Viking Global Investors
Alliancebernstein
Geode Capital Management
Eventide Asset Management

View all funds holding Trevi Therapeutics